Health Plan Rule Change Could Increase Patient Costs
The Department of Health and Human Services (HHS) this week finalized the 2021 Notice of Benefit and Payment Parameters, which sets the rules for health care plans in the coming year.
Remove Hurdles to Cancer Care Press Releases
Cancer Group Urges N.C. COVID-19 Committee to Enact Legislation to Safeguard Cancer Patients and Increase Access to Care
Raleigh, N.C.—In response to the N.C.
Administration’s Budget Risks Reversing Progress Against Cancer
The administration released its FY21 budget today which contains significant cuts to health care programs. If implemented, the cuts could leave millions more Americans uninsured and unable to access comprehensive health coverage and stall medical research essential to preventing, detecting and treating cancer.
Lawmakers Consider Funding Deal; Includes $2.6 Billion Boost for Medical Research
Congress is poised to pass a funding bill this week that includes a $2.6 billion increase for medical research at the National Institutes of Health (NIH). The measure, agreed upon by both House and Senate conference committee members, also provides $296 million increase for the National Cancer Institute (NCI).
House to Vote on Comprehensive Drug Pricing Legislation, Provisions Include Capping Medicare Patients’ Out-of-Pocket Prescription Drug Costs
The U.S. House will vote today on a bill intended to bring down patient prescription drug costs. Several of the bill’s provisions are important to cancer care, including establishing an annual cap on Medicare enrollees’ out-of-pocket expenses, allowing some Medicare beneficiaries to spread out high-cost prescription cost-sharing over the course of the year, and expanding Medicare eligibility for low-income subsidies.
House Leadership Proposes Broad Legislation to Reduce Patient Out-Of-Pocket Drug Costs
House Speaker, Nancy Pelosi (D-Calif.), introduced legislation intended to bring down patient drug costs.
Senate Finance Committee Proposes Capping Medicare Patients’ Out-of-Pocket Prescription Drug Costs in Drug Pricing Bill
Today the Senate Finance Committee is marking up the Prescription Drug Pricing Reduction Act (PDPRA) of 2019, which includes a provision to cap Medicare beneficiaries’ out-of-pocket prescription drug costs in Medicare Part D, among several other proposed changes intended to bring down patient costs.
House Subcommittee Considers Bills Addressing Patient Health Care Costs and Access Issues
Today the House Energy and Commerce Subcommittee on Health will mark-up a series of bills aimed at reducing patient out-of-pocket costs and preserving access to health care. Specifically, the committee will consider a measure that would exempt patients from having to pay surprise medical bills in most circumstances.
Bipartisan Health Package Offers Path Toward Reducing Patients’ Out-Of-Pocket Costs; Improving Public Health
Today the Senate Health, Education, Labor and Pensions Committee will markup legislation aimed at helping reduce patients’ out-of-pocket health care costs and improving public health. The Lower Health Care Costs Act would exempt patients from having to pay surprise medical bills in most circumstances.
HHS Hears Cancer Patients’ Concerns About Timely Access to Drug Therapies in Medicare Part D
Today the Department of Health and Human Services (HHS) issued its final rule for Medicare Part D which does not include the full range of proposed changes to drugs in the ‘six protected classes’ of cancer, epilepsy, HIV/AIDS, mental illness and organ transplants.